Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Viswanatha

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Haematologica|July 17, 2025
Characteristics of patients with newly diagnosed acute myeloid leukemia not receiving treatmentOudai Alkabbani, Yazan Jabban, Rong He, et al.
Blood Cancer Journal|September 6, 2023
Prospective evaluation of genome sequencing to compare conventional cytogenetics in acute myeloid leukemiaBeth A Pitel, Cinthya Zepeda-Mendoza, Zohar Sachs, et al.
American Journal of Hematology|June 15, 2022
A dynamic 3-factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapyAyalew Tefferi, Naseema Gangat, Aref Al-Kali, et al.
American Journal of Clinical Pathology|August 8, 2022
Abnormal CD13/HLA-DR Expression Pattern on Myeloblasts Predicts Development of Myeloid Neoplasia in Patients With Clonal Cytopenia of Undetermined SignificanceDragan Jevremovic, Ahmad Nanaa, Susan M Geyer, et al.
American Journal of Hematology|August 14, 2021
Spectrum of hematological malignancies, clonal evolution and outcomes in 144 Mayo Clinic patients with germline predisposition syndromesEmma St Martin, Alejandro Ferrer, Abhishek A Mangaonkar, et al.
Mayo Clinic Proceedings|June 6, 2018
Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical InformationAyalew Tefferi, Naseema Gangat, Mythri Mudireddy, et al.
Blood|April 21, 2023
Spectrum of clonal hematopoiesis in VEXAS syndromeFernanda Gutierrez-Rodrigues, Yael Kusne, Jenna Fernandez, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Haematologica|July 17, 2025
Characteristics of patients with newly diagnosed acute myeloid leukemia not receiving treatmentOudai Alkabbani, Yazan Jabban, Rong He, et al.
Blood Cancer Journal|September 6, 2023
Prospective evaluation of genome sequencing to compare conventional cytogenetics in acute myeloid leukemiaBeth A Pitel, Cinthya Zepeda-Mendoza, Zohar Sachs, et al.
American Journal of Hematology|June 15, 2022
A dynamic 3-factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapyAyalew Tefferi, Naseema Gangat, Aref Al-Kali, et al.
American Journal of Clinical Pathology|August 8, 2022
Abnormal CD13/HLA-DR Expression Pattern on Myeloblasts Predicts Development of Myeloid Neoplasia in Patients With Clonal Cytopenia of Undetermined SignificanceDragan Jevremovic, Ahmad Nanaa, Susan M Geyer, et al.
American Journal of Hematology|August 14, 2021
Spectrum of hematological malignancies, clonal evolution and outcomes in 144 Mayo Clinic patients with germline predisposition syndromesEmma St Martin, Alejandro Ferrer, Abhishek A Mangaonkar, et al.
Mayo Clinic Proceedings|June 6, 2018
Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical InformationAyalew Tefferi, Naseema Gangat, Mythri Mudireddy, et al.
Blood|April 21, 2023
Spectrum of clonal hematopoiesis in VEXAS syndromeFernanda Gutierrez-Rodrigues, Yael Kusne, Jenna Fernandez, et al.
Pageof 6